The Effects of a Mediterranean Diet on the Need for Diabetes Drugs and Remission of Newly Diagnosed Type 2 Diabetes: Follow-up of a Randomized Trial
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the long-term effects of dietary interventions on glycemic control, need for diabetes medications, and remission of type 2 diabetes. RESEARCH DESIGN AND METHODS: Originally, in a two-arm trial design, overweight, middle-aged men and women with newly diagnosed type 2 diabetes were randomized to a low-carbohydrate Mediterranean diet (LCMD; n = 108) or a low-fat diet (n = 107). After 4 years, participants who were still free of diabetes medications were further followed up until the primary end point (need of a diabetic drug); remission of diabetes (partial or complete) and changes in weight, glycemic control, and cardiovascular risk factors were also evaluated. RESULTS: The primary end point was reached in all participants after a total follow-up of 6.1 years in the low-fat group and 8.1 years in the LCMD group; median survival time was 2.8 years (95% CI 2.4–3.2) and 4.8 years (4.3–5.2), respectively. The unadjusted hazard ratio for the overall follow-up was 0.68 (0.50–0.89; P < 0.001). LCMD participants were more likely to experience any remission (partial or complete), with a prevalence of 14.7% (13.0–16.5%) during the first year and 5.0% (4.4–5.6%) during year 6 compared with 4.1% (3.1–5.0%) at year 1 and 0% at year 6 in the low-fat diet group. CONCLUSIONS: In patients with newly diagnosed type 2 diabetes, an LCMD resulted in a greater reduction of HbA1c levels, higher rate of diabetes remission, and delayed need for diabetes medication compared with a low-fat diet.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence of T2D remission beyond two years is sparse, with examples in bariatric surgery and following the three lifestyle interventions: 1) meal replacements for caloric restriction and physical activity [5,7,8]; 2) short-term total diet replacement with rescue therapy for weight maintenance [9]; and 3) a calorie-restricted Mediterranean diet [10].”
In the citing paper
“Remission was elicited among 7.3 % at four years by the intensive lifestyle intervention in the Look AHEAD randomized controlled trial utilizing meal replacements and physical activity [6], among 13 % of people treated five years in the DiRECT trial with initial total diet replacement with ongoing rescue therapy [9], and among 5 % at six years in the Mediterranean diet group in the randomized”
In the citing paper
“Greater diabetes remission in the CCI vs. Look AHEAD ILI could result from differences in the dietary intervention (23), patients' ability to self-select their lifestyle change or effectiveness of continuous remote care.”
In the citing paper
“A low-carbohydrate Mediterranean diet caused remission in 14.7% of newly diagnosed diabetes patients at 1 year vs. 4.1% with a low-fat diet (23)”
In the citing paper
“in an RCT by Esposito et al. (179), despite only a 2-kg difference in weight loss, the group following a low-carbohydrate Mediterranean-style eating pattern (see Table 3) experienced greater rates of at least partial diabetes remission, with rates of 14.7% at year 1 and 5% at year 6 compared with 4.7% and 0%, respectively, in the group following a low-fat eating plan.”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [179]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · cited 1×
“As chronic inflammation is predictive of the future occurrence of both type 2 diabetes (20) and cardiovascular events (21), it is likely that the proposed anti-”
BackgroundIDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors
Murray, C. J. L. (2013) · JAMA · doi:10.1001/jama.2013.13805 · Cited by 2,438
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Self-citationComparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966 · cited 1×
“(3) and with intermediate outcomes such as weight gain, increased blood pressure, and insulin resistance and hyperglycemia (4,5).”
BackgroundThe Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Emergency Hospitalizations for Adverse Drug Events in Older Americans
Budnitz, D. S., Lovegrove, M. C., Shehab, N., & Richards, C. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1103053 · Cited by 1,820 · cited 1×
“The ability to eliminate diabetes medications should considerably reducemedication costs, related adverse effects, risks of hypoglycemia, and hyperglycemic symptoms (25,26); even delaying the onset of diabetes can have a substantial effect on sub-”
BackgroundMeasuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Sofi, F., Abbate, R., Gensini, G. F., & Casini, A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29673 · Cited by 1,605 · cited 1×
“While observational studies have shown that adherence to Med diets reduces the risk of death due to cardiovascular disease and cancer (24), there are very few long-term interventional studies with Med diets.”
BackgroundLi, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600 · cited 1×
“Lifestyle-intervention studies have shown the benefit of healthy lifestyle on delaying or postponing the deterioration of glucose tolerance to manifest type 2 diabetes (from 30 to 67%) (15,16).”
BackgroundEsposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511
Self-citationHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003 · cited 1×
“Moreover, the appropriate definition of diabetes remission remains an area of ambiguity and debate (28).”
BackgroundInternational Physical Activity Questionnaire: Validity against Fitness
FOGELHOLM, M., MALMBERG, J., SUNI, J., SANTTILA, M., KYRÖLÄINEN, H., MÄNTYSAARI, M., & OJA, P. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000194075.16960.20 · Cited by 977
Bolen, S., Feldman, L., Vassy, J., Wilson, L., Yeh, H.-C., Marinopoulos, S., Wiley, C., Selvin, E., Wilson, R., Bass, E. B., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00178 · Cited by 823 · cited 1×
“The ability to eliminate diabetes medications should considerably reducemedication costs, related adverse effects, risks of hypoglycemia, and hyperglycemic symptoms (25,26); even delaying the onset of diabetes can have a substantial effect on sub-”
BackgroundAssociation of an intensive lifestyle intervention with remission of type 2 diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.67929 · Cited by 752
Behavioral and Dietary Risk Factors for Noncommunicable Diseases
Ezzati, M., & Riboli, E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1203528 · Cited by 740 · cited 1×
“This increase in type 2 diabetes is inextricably linked to changes toward a Western lifestyle (high-energy diets with reduced physical activity) in developing countries and the rise in the prevalence of overweight and obesity (2).”
BackgroundHerman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Components of a Cardioprotective Diet: New Insights
Mozaffarian, D., Appel, L. J., & Van Horn, L. (2011) · Circulation · doi:10.1161/circulationaha.110.968735 · Cited by 571 · cited 1×
“(3) and with intermediate outcomes such as weight gain, increased blood pressure, and insulin resistance and hyperglycemia (4,5).”
BackgroundEsposito, K., Ida Maiorino, M., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181e5a159 · Cited by 460 · cited 2×
“In a previous intervention trial (12), patients with newly diagnosed type 2 diabetes who were assigned to a lowcarbohydrate Med diet (LCMD) were less likely to need oral therapy for hyperglycemia than patients assigned to a low-fat diet.”
BackgroundMethodSelf-citationDiet and inflammation: a link to metabolic and cardiovascular diseases
Esposito, K., & Giugliano, D. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi605 · Cited by 233 · cited 1×
“Epidemiologic and interventional studies have revealed a protective effect of Med diets against chronic inflammation, insulin resistance, and the metabolic syndrome (6,17) associated with increased circulating levels of adiponectin (18,19).”
BackgroundSelf-citationEsposito, K., Kastorini, C.-M., Panagiotakos, D. B., & Giugliano, D. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0009 · Cited by 127 · cited 2×
“Moreover, a meta-analysis (3) of 10 studies yielded a 32% reduction of risk of future type 2 diabetes associated with healthy dietary patterns.”
BackgroundSelf-citationClinical Value of Drugs Targeting Inflammation for the Management of Coronary Artery Disease
Duchatelle, V., Kritikou, E. A., & Tardif, J. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.05.003 · Cited by 15 · cited 1×
“As chronic inflammation is predictive of the future occurrence of both type 2 diabetes (20) and cardiovascular events (21), it is likely that the proposed anti-”
BackgroundEsposito, K., Maiorino, M. I., Ciotola, M., Di Palo, C., Scognamiglio, P., Gicchino, M., Petrizzo, M., Saccomanno, F., Beneduce, F., Ceriello, A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00004 · Cited by 13
Self-citationLifestyle and Adiponectin Level: Four-Year Follow-up of Controlled Trials
Esposito, K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.246 · Cited by 4 · cited 1×
“Epidemiologic and interventional studies have revealed a protective effect of Med diets against chronic inflammation, insulin resistance, and the metabolic syndrome (6,17) associated with increased circulating levels of adiponectin (18,19).”
BackgroundSelf-citation
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
“(179), despite only a 2-kg difference in weight loss, the group following a low-carbohydrate Mediterranean-style eating pattern (see Table 3) experienced greater rates of at least partial diabetes remission, with rates of 14.”
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses
Esposito, K., Maiorino, M. I., Bellastella, G., Chiodini, P., Panagiotakos, D., & Giugliano, D. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008222 · Cited by 501
Self-citationFunctional Foods and Lifestyle Approaches for Diabetes Prevention and Management
Alkhatib, A., Tsang, C., Tiss, A., Bahorun, T., Arefanian, H., Barake, R., Khadir, A., & Tuomilehto, J. (2017) · Nutrients · doi:10.3390/nu9121310 · Cited by 376
“7% and 5% reduced reliance on medication at one and five years post-diagnosis, respectively, compared with a low-fat diet [28].”
Background
Metadata
- Authors
- Esposito, K., Maiorino, M. I., Petrizzo, M., Bellastella, G., & Giugliano, D.
- Affiliations
- University of Campania "Luigi Vanvitelli" (IT)
- Corresponding author
- Esposito, Katherine
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-06-12
- Volume
- 37
- Issue
- 7
- Pages
- 1824-1830
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2129650435
- Cited by
- 205
- References
- 30
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 16 · 2023: 16 · 2022: 23 · 2021: 20 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 16 · 2016: 11 · 2015: 8 · 2014: 8
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- Mediterranean diet, low-carbohydrate diet, low-fat diet, type 2 diabetes, newly diagnosed diabetes, diabetes remission, glycemic control, HbA1c, dietary intervention, cardiovascular risk factors, weight change
- MeSH terms
- Adult, Blood Glucose, Body Weight, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Remission Induction, Risk Factors, Time Factors, Diet, Fat-Restricted, Diet, Mediterranean, Overweight, Diet, Carbohydrate-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.